How to get the best from Mounjaro: the decisions that actually matter

Decision one: NHS route or private clinic, and why that choice shapes your start date

Most people searching for Mounjaro are trying to work out how long they'll wait. The NHS route exists, but the criteria are strict and the rollout is phased, getting Mounjaro through your GP currently requires a BMI of 40 or above alongside four or more qualifying conditions (high blood pressure, dyslipidaemia, sleep apnoea, cardiovascular disease, or type 2 diabetes), and not every GP practice is participating even now. For many people, that means a private licensed pharmacy is the realistic option today. The key legal point is the same either way: Mounjaro cannot be supplied without a valid prescription following a proper clinical assessment. Any website skipping that step is operating outside UK law, full stop.

A private online pharmacy registered with the GPhC (you can verify our registration number 9012878 directly on the GPhC register) can prescribe and dispense Mounjaro without a GP referral or waiting list, provided you meet the clinical criteria. The prescriber still reviews your full health picture; the difference is speed and access, not a lower bar.

Decision two: choosing a pharmacy worth trusting, not just the cheapest listing

The MHRA has issued repeated public warnings about fake tirzepatide pens circulating online and via social media, including an October 2025 raid on an illicit UK manufacturing site in Northampton producing counterfeit pens. Buying from an unverified seller (one offering Mounjaro without a formal consultation, or at prices far below the market) carries genuine physical risk. Counterfeit pens have been found to contain the wrong substance entirely. The enforcement figures are stark: roughly 20 million doses of illegally traded weight-loss medicines, worth around £45 million, were seized in 2025 alone. Read the MHRA's Yellow Card scheme if you want to report a suspect seller or a reaction to a medicine.

The one-minute check before ordering anywhere: look the pharmacy up on the GPhC register. If it is not listed, stop. If it is offering these medicines without asking for a consultation or any clinical history, that is a red flag regardless of the price. Speed is not a substitute for safety. For more on what to look for when choosing a supplier, our guide to finding a reputable Mounjaro provider covers the practical checklist.

Decision three: understanding eligibility so you go in prepared

UK licensing sets the eligibility floor: adults aged 18 or over with a BMI of 30 or higher, or a BMI of 27 or higher if a weight-related condition is present. Lower BMI thresholds apply for certain ethnic backgrounds under UK guidance, a prescriber will take this into account. What the licence does not do is guarantee approval; contraindications, current medications and medical history all factor in. A history of medullary thyroid carcinoma, pancreatitis or certain gastrointestinal conditions requires careful prescriber discussion.

At nume, the consultation is free and covers all of this. A GPhC-registered Independent Prescriber (not software) reads your answers and supporting information on the same day. Transfer patients and anyone requesting a dose increase provide evidence as part of that review. If you are curious how tirzepatide fits alongside other licensed options, the treatment overview puts it in context. The full clinical picture is what getting strong results from Mounjaro actually depends on, a good match between the medicine and your circumstances, agreed with a prescriber from the start.

Decision four: what comes after the prescription matters as much as getting it

The consultation is the beginning, not the whole job. Tirzepatide starts at 2.5mg (a dose chosen to let your body adjust, not to produce dramatic early results) and is titrated by your prescriber over subsequent months. That ongoing clinical relationship is where a lot of services fall short: auto-renewals dispatched without review, no one available when side effects spike at a dose increase, no help when a delivery goes wrong. The NICE appraisal of tirzepatide (TA1026) includes a recommendation to review response after six months at the highest tolerated dose; in practice, that review needs a real prescriber looking at real progress, not a checkbox.

At nume there are no subscriptions and no auto-renewals. Every repeat order goes back to a prescriber for clinical re-review before anything is dispatched. If a delivery misses you, our page on missed Mounjaro deliveries explains exactly how that is handled. Questions between doses go to 7-day aftercare, answered by the clinical team. Read more about practical steps that support your progress on Mounjaro, including guidance on how to get the rest of the Mounjaro out of the pen, or learn more about how nume works before you start.